CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 92 filers reported holding CUE BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is 2.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $10,837,000 | +32.1% | 743,772 | +5.6% | 0.42% | +49.5% |
| Q2 2021 | $8,204,000 | +99.3% | 704,220 | +108.7% | 0.28% | +29.8% |
| Q1 2021 | $4,117,000 | +2.8% | 337,428 | +5.4% | 0.22% | +15.3% |
| Q4 2020 | $4,003,000 | -16.9% | 320,000 | 0.0% | 0.19% | -46.5% |
| Q3 2020 | $4,816,000 | -38.6% | 320,000 | 0.0% | 0.35% | -43.8% |
| Q2 2020 | $7,843,000 | -13.6% | 320,000 | -50.0% | 0.63% | +17.4% |
| Q1 2020 | $9,082,000 | +78.8% | 640,000 | +100.0% | 0.54% | -7.9% |
| Q4 2019 | $5,080,000 | +100.9% | 320,000 | +6.7% | 0.58% | +106.8% |
| Q3 2019 | $2,529,000 | – | 300,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,545,573 | $3,447,000 | 1.85% |
| P.A.W. CAPITAL CORP | 200,000 | $446,000 | 0.67% |
| SANDERS MORRIS HARRIS LLC | 848,048 | $2,020,000 | 0.50% |
| Monaco Asset Management SAM | 458,851 | $1,023,000 | 0.39% |
| Bleichroeder LP | 555,000 | $1,238,000 | 0.26% |
| APOGEM CAPITAL LLC | 110,614 | $247,000 | 0.25% |
| Slate Path Capital LP | 1,483,619 | $3,308,000 | 0.22% |
| Voss Capital, LLC | 200,000 | $446,000 | 0.13% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $1,067,000 | 0.11% |
| CARLSON CAPITAL L P | 535,000 | $1,193,000 | 0.09% |